Sinovac Biotech Ltd
NASDAQ: SVA
=
5.93
0.00
0.00%
1 Day
-
Open
5.89
-
Previous Close
5.93
-
Volume (Avg)
1.20k (68.23k)
-
Day's Range
5.89-5.93
-
52Wk Range
4.38-7.16
-
Market Cap.
337.46M
-
Dividend Rate ( Yield)
-
-
Beta
0.35
-
Shares Outstanding
56.91M
-
P/E Ratio (EPS)
-
Top Stories
-
Influenza Vaccines Market 2016: Global Industry Insights, Statistics, Market shares and Forecasts to 2022
qwtjlive.com 9/19/2016 -
Acorda Therapeutics Inc versus Sinovac Biotech Ltd. Head to Head Compare
news.cmlviz.com -
Sinovac Reports Unaudited Second Quarter 2016 Financial Results
ih.advfn.com -
Sinovac Reports Unaudited Second Quarter 2016 Financial ...
publicnow.com -
Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results
en.prnasia.com 8/15/2016BEIJING, August 15, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter, ended June 30, 2016 ...
-
Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results
8 ABC kait8.com -
Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results
ih.advfn.com -
Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results
Fox 19 -
Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results
NBC 29 News -
Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results
6 WECT -
Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results
WRCB 3 Chattanooga -
Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results
Oklahoma's Own NewsOn6 -
Sinovac Files 2015 Annual Report on Form 20-F
prnewswire.com -
Sinovac Biotech Ltd. :SVA-US: Earnings Analysis: Q4, 2015 By the Numbers
capitalcube.com -
BRIEF-1Globe Capital reports 16.4 pct passive stake in Sinovac Biotech
Reuters 4/5/2016Sept 19 Wells Fargo & Co's chief executive, John Stumpf, will tell U.S. senators on Tuesday that he is "deeply sorry" for selling customers unauthorized bank accounts and credit cards and that he would take "full responsibility" for the unethical activity ...
-
The Top 5 Micro Cap Biotechnology Stocks for 2016 (BSTC, OSIR)
Investopedia -
Sinovac Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Independent Special Committee
prnewswire.com -
Sinovac Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Independent Special Committee
FiercePharma
